News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PerkinElmer, Inc. (PKI) and Cerep, Inc. Announce Expansion of New Kinase Assay Offerings to Accelerate Drug Candidate Screening and Validation



4/28/2009 10:08:44 AM

LILLE, France--(BUSINESS WIRE)--At the 15th Annual Society for Biomolecular Sciences (SBS) Conference today, PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, and Cerep SA, a leading provider of drug candidate screening and profiling technologies, announced the expansion of their kinase assay offering. Close to 200 new kinase assays validated with PerkinElmer’s LANCE® UltraTM technology will be offered for use through Cerep’s drug candidates selection and qualification services.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES